MedTrace Logo

Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs

NCT04638569 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 116

Last updated 2022-02-07

No results posted yet for this study

Summary

Comparison of the obturator nerve block in patients undergoing transurethral resection due to bladder tumor, technically using ultrasound guided or blinded with anatomical signs.

Conditions

  • Succesful Obturator Nerve Block
  • Bladder Tumor
  • Bleeding

Interventions

PROCEDURE

obturator nerve block

The ultrasound probe will be placed in the middle of the tuberculum pubis and femoral artery, 5-6 cm below the inguinal ligament, and 5 mL of 0.5% bupivacaine will be injected into the anterior and posterior branches of the ON with a needle. In the second group, after the patient is placed in the lithotomy position, 1.5 cm lateral tuberculum pubis and 1.5 cm caudal will be marked and needle entry will be made and 0.5% bupivacaine will be injected with 10 mL. The time elapsed until the first needle insertion and local anesthetic injection is completed will be recorded as the application time.

Sponsors & Collaborators

  • Muğla Sıtkı Koçman University

    lead OTHER

Principal Investigators

  • Eylem Yaşar · Muğla Sıtkı Koçman University

  • Ali İhsan Uysal · Mugla Sitki Kocman University Department of Anesthesia

  • İlker Akarken · Mugla Sitki Kocman University Department of Urology

  • basak altiparmak · Mugla Sitki Kocman University Department of Anesthesia

  • semra demirbilek · Mugla Sitki Kocman University Department of Anesthesia

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-02-16
Primary Completion
2022-03-01
Completion
2022-09-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04638569 on ClinicalTrials.gov